124 related articles for article (PubMed ID: 18242984)
1. Constraining the amide bond in N-sulfonylated dipeptide VLA-4 antagonists.
Chang LL; Yang GX; McCauley E; Mumford RA; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2008 Mar; 18(5):1688-91. PubMed ID: 18242984
[TBL] [Abstract][Full Text] [Related]
2. Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists.
Reger TS; Zunic J; Stock N; Wang B; Smith ND; Munoz B; Green MD; Gardner MF; James JP; Chen W; Alves K; Si Q; Treonze KM; Lingham RB; Mumford RA
Bioorg Med Chem Lett; 2010 Feb; 20(3):1173-6. PubMed ID: 20022493
[TBL] [Abstract][Full Text] [Related]
3. N-aryl-prolyl-dipeptides as potent antagonists of VLA-4.
Kamenecka TM; Lanza T; de Laszlo SE; Li B; McCauley ED; Van Riper G; Egger LA; Kidambi U; Mumford RA; Tong S; MacCoss M; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Aug; 12(16):2205-8. PubMed ID: 12127538
[TBL] [Abstract][Full Text] [Related]
4. The discovery and potential of N-sulfonylated dipeptide VLA-4 antagonists.
Hagmann WK
Curr Top Med Chem; 2004; 4(14):1461-71. PubMed ID: 15544537
[TBL] [Abstract][Full Text] [Related]
5. Amidines as amide bond replacements in VLA-4 antagonists.
Kamenecka TM; Park YJ; Lin LS; de Laszlo S; McCauley ED; Van Riper G; Egger L; Kidambi U; Mumford RA; Tong S; Tang W; Colletti A; Teffera Y; Stearns R; MacCoss M; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2004 May; 14(9):2323-6. PubMed ID: 15081033
[TBL] [Abstract][Full Text] [Related]
6. The discovery of sulfonylated dipeptides as potent VLA-4 antagonists.
Hagmann WK; Durette PL; Lanza T; Kevin NJ; de Laszlo SE; Kopka IE; Young D; Magriotis PA; Li B; Lin LS; Yang G; Kamenecka T; Chang LL; Wilson J; MacCoss M; Mills SG; Van Riper G; McCauley E; Egger LA; Kidambi U; Lyons K; Vincent S; Stearns R; Colletti A; Teffera J; Tong S; Fenyk-Melody J; Owens K; Levorse D; Kim P; Schmidt JA; Mumford RA
Bioorg Med Chem Lett; 2001 Oct; 11(20):2709-13. PubMed ID: 11591507
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potential integrin VLA-4 antagonists using pharmacophore modeling, virtual screening and molecular docking studies.
Thangapandian S; John S; Sakkiah S; Lee KW
Chem Biol Drug Des; 2011 Aug; 78(2):289-300. PubMed ID: 21507205
[TBL] [Abstract][Full Text] [Related]
8. 2,6-Quinolinyl derivatives as potent VLA-4 antagonists.
Lassoie MA; Broeders F; Collart P; Defrère L; de Laveleye-Defais F; Demaude T; Gassama A; Guillaumet G; Hayez JC; Kiss L; Knerr L; Nicolas JM; Norsikian S; Quéré L; Routier S; Verbois V; Provins L
Bioorg Med Chem Lett; 2007 Jan; 17(1):142-6. PubMed ID: 17035017
[TBL] [Abstract][Full Text] [Related]
9. Pyridone derivatives as potent and selective VLA-4 integrin antagonists.
Witherington J; Bordas V; Gaiba A; Green PM; Naylor A; Parr N; Smith DG; Takle AK; Ward RW
Bioorg Med Chem Lett; 2006 Apr; 16(8):2256-9. PubMed ID: 16455247
[TBL] [Abstract][Full Text] [Related]
10. Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4.
Lin LS; Lanza TJ; Castonguay LA; Kamenecka T; McCauley E; Van Riper G; Egger LA; Mumford RA; Tong X; MacCoss M; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2004 May; 14(9):2331-4. PubMed ID: 15081035
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.
Rehman A; Soni A; Naik K; Nair S; Palle VP; Dastidar S; Ray A; Alam MS; Salman M; Cliffe IA; Sattigeri V
Bioorg Med Chem Lett; 2010 Sep; 20(18):5514-20. PubMed ID: 20705461
[TBL] [Abstract][Full Text] [Related]
12. Imidazopyridines as VLA-4 integrin antagonists.
Phillips DJ; Davenport RJ; Demaude TA; Galleway FP; Jones MW; Knerr L; Perry BG; Ratcliffe AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):4146-9. PubMed ID: 18539454
[TBL] [Abstract][Full Text] [Related]
13. Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3',5'-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist.
Venkatraman S; Lebsack AD; Alves K; Gardner MF; James J; Lingham RB; Maniar S; Mumford RA; Si Q; Stock N; Treonze KM; Wang B; Zunic J; Munoz B
Bioorg Med Chem Lett; 2009 Oct; 19(19):5803-6. PubMed ID: 19713111
[TBL] [Abstract][Full Text] [Related]
14. The identification and optimization of orally efficacious, small molecule VLA-4 antagonists.
Huryn DM; Konradi AW; Ashwell S; Freedman SB; Lombardo LJ; Pleiss MA; Thorsett ED; Yednock T; Kennedy JD
Curr Top Med Chem; 2004; 4(14):1473-84. PubMed ID: 15544538
[TBL] [Abstract][Full Text] [Related]
15. Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist.
Chiba J; Machinaga N; Takashi T; Ejima A; Takayama G; Yokoyama M; Nakayama A; Baldwin JJ; McDonald E; Moriarty KJ; Sarko CR; Saionz KW; Swanson R; Hussain Z; Wong A
Bioorg Med Chem Lett; 2005 Jan; 15(1):41-5. PubMed ID: 15582407
[TBL] [Abstract][Full Text] [Related]
16. A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid.
Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2009 Feb; 17(3):1232-43. PubMed ID: 19124247
[TBL] [Abstract][Full Text] [Related]
17. Influence of acid surrogates toward potency of VLA-4 antagonist.
Venkatraman S; Lim J; Cramer M; Gardner MF; James J; Alves K; Lingham RB; Mumford RA; Munoz B
Bioorg Med Chem Lett; 2005 Sep; 15(18):4053-6. PubMed ID: 16039122
[TBL] [Abstract][Full Text] [Related]
18. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation.
Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC
Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516
[TBL] [Abstract][Full Text] [Related]
19. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.
Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y
Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288
[TBL] [Abstract][Full Text] [Related]
20. Identification of unique VLA-4 antagonists from a combinatorial library.
de Laszlo SE; Li B; McCauley E; Van Riper G; Hagmann WK
Bioorg Med Chem Lett; 2002 Feb; 12(4):685-8. PubMed ID: 11844701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
